Skip to main content
logo
Osang Healthcare Co.,Ltd (KOSDAQ:036220)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,410.00
+50.00 (0.79%)
Sep 11, 2026, 3:30 PM KST

Osang Healthcare Co.,Ltd Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-8,4573,109-11,364116,43640,6471,460
Depreciation & Amortization
8,4347,8667,1566,3355,4133,956
Loss (Gain) From Sale of Assets
-28.18-33.8-6.691,640-216.07-5.33
Asset Writedown & Restructuring Costs
37.9891.418.439.690.070.68
Loss (Gain) From Sale of Investments
-3,58275.3556.54104.99984.88-1,321
Loss (Gain) on Equity Investments
-1,211-652.652,791-925.89-259.8-913.21
Stock-Based Compensation
915.52963.931,3481,8602,6963,094
Provision & Write-off of Bad Debts
729.12-700.61-460.563,3232,06921,600
Other Operating Activities
2,045-981.19-27,92311,62618,811-24,190
Change in Accounts Receivable
25,008-6,5781,80420,216-18,5271,128
Change in Inventory
4,5995,728-7,99520,101-26,9464,193
Change in Accounts Payable
-324.82287.93-4,885-14,58112,089-1,015
Change in Unearned Revenue
-5.41-0.4311.339.95.81-
Change in Other Net Operating Assets
-6,170-2,962682.85-13,5595,5862,819
Operating Cash Flow
21,9906,213-38,767152,59642,35310,807
Operating Cash Flow Growth
---260.29%291.90%-89.32%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-14,792-16,094-27,810-35,703-11,702-9,040
Sale of Property, Plant & Equipment
79.2340.3654.1914,607715.0587.98
Sale (Purchase) of Intangibles
-2,034-2,915-4,629-179.72-199-858.77
Investment in Securities
-10,341-11,521-23,808-34,251-16,3093,722
Other Investing Activities
0-00-10
Investing Cash Flow
-27,087-30,490-56,192-55,526-27,495-6,079

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
---14,850-100
Long-Term Debt Issued
-43,913----
Total Debt Issued
8,35943,913-14,850-100
Short-Term Debt Repaid
----14,850--2,100
Long-Term Debt Repaid
--577.91-477.49-592.47-625.08-302.05
Total Debt Repaid
-1,163-577.91-477.49-15,442-625.08-2,402
Net Debt Issued (Repaid)
7,19643,335-477.49-592.47-625.08-2,302
Issuance of Common Stock
-230.3123,154714.382,570294.61
Repurchase of Common Stock
---4,994---
Dividends Paid
-2,750-6,856-25,169-25,349-24,895-24,534
Other Financing Activities
-0-013.23--0
Financing Cash Flow
4,44536,709-7,473-25,227-22,950-26,541

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
1,052-204.872,180-366.29-874.7418.02
Net Cash Flow
400.2212,227-100,25371,476-8,966-21,795

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
7,198-9,881-66,577116,89330,6511,768
Free Cash Flow Growth
---281.36%1634.00%-98.11%
Free Cash Flow Margin
7.46%-7.68%-82.72%32.85%15.81%1.34%
Free Cash Flow Per Share
523.89-717.32-4903.488955.922387.99143.73
Levered Free Cash Flow
4,442-15,115-69,28493,87434,6897,542
Unlevered Free Cash Flow
5,135-14,422-69,26793,91034,7057,552

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
1,5291,10927.174925.128.75
Cash Income Tax Paid
--1,33317,02233,8361,31136,540
Change in Working Capital
23,107-3,524-10,38212,187-27,7927,125